Studies show hydroxychloroquine does not have clinical benefits in treating Covid-19
Current data shows that this drug does not reduce deaths among hospitalised Covid-19 patients, nor help people with mild or moderate disease.
According to the World Health Organisation studies show that hydroxychloroquine does not have clinical benefits in treating Covid-19
Hydroxychloroquine or chloroquine, a treatment for malaria, lupus erythematosus, and rheumatoid arthritis, has been under study as a possible treatment for Covid-19.
Current data shows that this drug does not reduce deaths among hospitalised Covid-19 patients, nor help people with mild or moderate disease.
The use of hydoxychloroquine and chloroquine is accepted as generally safe for patients with malaria and autoimmune diseases, but its use where not indicated and without medical supervision can cause serious side effects and should be avoided.
Source: World Health Organization (WHO)
Dear reader,
As your local news provider, we have the duty of keeping you factually informed on Covid-19 developments. As you may have noticed, mis- and disinformation (also known as “fake news”) is circulating online. Caxton Local Media is determined to filter through the masses of information doing the rounds and to separate truth from untruth in order to keep you adequately informed. Local newsrooms follow a strict pre-publication fact-checking protocol. A national task team has been established to assist in bringing you credible news reports on Covid-19.
Read original story on bedfordviewedenvalenews.co.za
